Table 4. Sequences for the IA-modified peptide fragments of Cys32 and Cys250 after hAS3MT-catalyzed the iAs3+ methylation.
Sequence site | Mr (calc) | GSH system | Cys system | DTT system | TCEP system | ||||
Mr (expt) | ppm | Mr (expt) | ppm | Mr (expt) | ppm | Mr (expt) | ppm | ||
24–44 | 2320.21 | 2320.15 | −25.86 | 2319.71 | −215.54 | 2320.08 | −56.03 | 2319.96 | −107.76 |
24–41 | 1913.96 | 1914.18 | 114.93 | 1914.23 | 141.05 | 1914.13 | 88.81 | 1913.87 | −47.03 |
242–258 | 2054.04 | 2054.35 | 150.90 | 2054.34 | 146.03 | 2054.31 | 131.43 | 2053.81 | −111.99 |
242–251 | 1245.61 | 1245.78 | 136.46 | 1245.52 | −72.26 | 1245.72 | 88.30 | 1245.39 | −176.65 |
246–261 | 1915.01 | 1914.89 | −62.67 | 1915.12 | 57.44 | 1915.99 | −15.67 | 1915.04 | 15.67 |
246–258 | 1526.77 | 1526.69 | −52.40 | 1526.65 | −78.60 | 1526.71 | −39.3 | 1526.58 | −124.46 |
Values of Mr (expt) are calculated from the results of MALDI-TOF-MS in Figure 3. ND represents the peptide fragment is not detected.